PMID- 32928091
OWN - NLM
STAT- MEDLINE
DCOM- 20210527
LR  - 20210527
IS  - 1875-6417 (Electronic)
IS  - 1573-3998 (Linking)
VI  - 17
IP  - 4
DP  - 2021
TI  - Knowledge and Perceptions Towards Cardiovascular Disease Prevention Among 
      Patients with Type 2 Diabetes Mellitus: A Review of Current Assessments and 
      Recommendations.
PG  - 503-511
LID - 10.2174/1573399816666200914140939 [doi]
AB  - INTRODUCTION: Patients with type 2 diabetes mellitus (T2DM) are at significantly 
      higher risk of developing cardiovascular diseases (CVD). There is a scarcity of 
      literature reviews that describe and summarize T2DM patients' knowledge and 
      perception about CVD prevention. OBJECTIVES: To describe and summarize the 
      assessment of knowledge and perceptions about CVD risk and preventive approaches 
      among patients with T2DM. METHODS: A scoping review methodology was adopted, and 
      three scientific databases, Google Scholar, Science Direct, and PubMed were 
      searched using predefined search terms. A multistage screening process that 
      considered relevancy, publication year (2009-2019), English language, and article 
      type (original research) was followed. We formulated research questions focused 
      on the assessment of levels of knowledge and perceptions of the illness relevant 
      to CVD prevention and the identification of associated patients' characteristics. 
      RESULTS: A total of 16 studies were included. Patients were not confident to 
      identify CVD risk and other clinical consequences that may occur in the 
      prognostic pathway of T2DM. Furthermore, patients were less likely to identify 
      all CV risk factors indicating a lack of understanding of the multi-- factorial 
      contribution of CVD risk. Patients' beliefs about medications were correlated 
      with their level of adherence to medications for CVD prevention. Many knowledge 
      gaps were identified, including the basic disease expectations at the time of 
      diagnosis, identification of individuals' CVD risk factors, and management 
      aspects. Knowledge and perceptions were affected by patients' demographic 
      characteristics, e.g., educational level, race, age, and area of residence. 
      CONCLUSION: There are knowledge gaps concerning the understanding of CVD risk 
      among patients with T2DM. The findings necessitate educational initiatives to 
      boost CVD prevention among patients with T2DM. Furthermore, these should be 
      individualized based on patients' characteristics, knowledge gaps, disease 
      duration, and estimated CVD risk.
CI  - Copyright(c) Bentham Science Publishers; For any queries, please email at 
      epub@benthamscience.net.
FAU - Elnaem, Mohamed Hassan
AU  - Elnaem MH
AD  - Department of Pharmacy Practice, Faculty of Pharmacy, International Islamic 
      University Malaysia, Kuantan, Pahang, Malaysia.
FAU - Elrggal, Mahmoud E
AU  - Elrggal ME
AD  - Department of Clinical Pharmacy, College of Pharmacy, Umm Al-Qura University, 
      Makkah Province, Saudi Arabia.
FAU - Syed, Nabeel
AU  - Syed N
AD  - Department of Clinical Pharmacy, College of Pharmacy, Jazan University, Saudi 
      Arabia.
FAU - Naqvi, Atta Abbas
AU  - Naqvi AA
AD  - Department of Pharmacy Practice, College of Clinical Pharmacy, Imam Abdulrahman 
      Bin Faisal University Dammam, Saudi Arabia.
FAU - Hadi, Muhammad Abdul
AU  - Hadi MA
AD  - Institute of Clinical Sciences, University of Birmingham, Edgbaston, Birmingham, 
      United Kingdom.
LA  - eng
PT  - Journal Article
PT  - Review
PL  - United Arab Emirates
TA  - Curr Diabetes Rev
JT  - Current diabetes reviews
JID - 101253260
SB  - IM
MH  - *Cardiovascular Diseases/epidemiology/prevention & control
MH  - *Diabetes Mellitus, Type 2/epidemiology/prevention & control
MH  - Humans
MH  - Perception
MH  - Risk Factors
OTO - NOTNLM
OT  - Knowledge
OT  - cardiovascular disease
OT  - diabetic patient
OT  - perception
OT  - risk prevention
OT  - type 2 diabetes mellitus
EDAT- 2020/09/16 06:00
MHDA- 2021/05/28 06:00
CRDT- 2020/09/15 05:33
PHST- 2020/06/12 00:00 [received]
PHST- 2020/08/07 00:00 [revised]
PHST- 2020/08/18 00:00 [accepted]
PHST- 2020/09/16 06:00 [pubmed]
PHST- 2021/05/28 06:00 [medline]
PHST- 2020/09/15 05:33 [entrez]
AID - CDR-EPUB-109912 [pii]
AID - 10.2174/1573399816666200914140939 [doi]
PST - ppublish
SO  - Curr Diabetes Rev. 2021;17(4):503-511. doi: 10.2174/1573399816666200914140939.